Diabetes Mellitus Type 2 — Effect of Moringa Leaf Capsules on Glycemic Control of Type 2 Diabetic Patients
Citation(s)
American Diabetes Association 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021 Jan;44(Suppl 1):S15-S33. doi: 10.2337/dc21-S002. Erratum In: Diabetes Care. 2021 Sep;44(9):2182.
Azeem S, Khan U, Liaquat A The increasing rate of diabetes in Pakistan: A silent killer. Ann Med Surg (Lond). 2022 Jun 3;79:103901. doi: 10.1016/j.amsu.2022.103901. eCollection 2022 Jul. No abstract available.
Haber SL, McMahon RP, Barajas J, Hayes AR, Hussein H Effects of Moringa oleifera in patients with type 2 diabetes. Am J Health Syst Pharm. 2020 Oct 30;77(22):1834-1837. doi: 10.1093/ajhp/zxaa255. No abstract available.
Omar SM, Musa IR, Osman OE, Adam I Assessment of glycemic control in type 2 diabetes in the Eastern Sudan. BMC Res Notes. 2018 Jun 8;11(1):373. doi: 10.1186/s13104-018-3480-9.
Owens FS 3rd, Dada O, Cyrus JW, Adedoyin OO, Adunlin G The effects of Moringa oleifera on blood glucose levels: A scoping review of the literature. Complement Ther Med. 2020 May;50:102362. doi: 10.1016/j.ctim.2020.102362. Epub 2020 Feb 28.
Shahbaz H, Gupta M Creatinine Clearance. 2023 May 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK544228/
Effect of Moringa Leaf Capsules on Glycemic Control of Type 2 Diabetic Patients- an Interventional Study
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
